Results: Among the 159 living donors, 103 (64.75%) were men and 56 (35.25%) were women.
Prevalência de marcadores microbiológicos em tecido ósseo de doadores e cadáveres do Banco de Tecidos Musculoesqueléticos de Passo Fundo
Palavras-chave: 
Introduction
Musculoskeletal tissue banks have presented significant progress over the recent years and have become a tool of immense importance for undertaking orthopedic surgical procedures of greater complexity, through providing a plentiful and safe supply of bone, fascial, chondral and ligament material for grafts. 1,2 Orthopedic surgeons' concern regarding disease transmission through bone grafts is diminishing because of the rigorous selection criteria, high sensitivity of serological tests and serial examinations performed during harvesting, storage, processing and sterilization of these grafts. [3] [4] [5] [6] [7] [8] The musculoskeletal tissue bank at Hospital São Vicente de Paulo (HSVP), in Passo Fundo, was founded in 1982, with adaptation to new legislation in 1995. Its aim is to adequately store bone and tendon tissue and thus benefit patient treatment in the orthopedic-traumatological and dental fields.
The present study aimed to retrospectively analyze the prevalence of the main microbiological markers in bone tissues in the musculoskeletal tissue bank at Hospital São Vicente de Paulo, in Passo Fundo, and the possible causes of rejection of material.
Materials and methods
Between August 2007 and October 2011, at Hospital São Vicente de Paulo, 202 musculoskeletal tissue-harvesting procedures were performed to acquire material for the tissue bank. Out of this total, 159 were from donors and 43 were from cadavers.
The donors underwent orthopedic surgical procedures for total hip arthroplasty in which the femoral head was removed. A questionnaire was applied and a detailed history of the donors' previous medical history was obtained. In addition, preoperative laboratory tests were run in order to detect infectious diseases. The following serological tests were requested: hepatitis B (anti-HBsAg and anti-total HBc), hepatitis C (anti-HCV), syphilis (hemagglutination of Treponema pallidum, VDRL), cytomegalovirus (anti-CMV IgG and IgM), Chagas disease (anti-T. cruzi), toxoplasmosis (anti-Toxoplasma IgG and IgM), HIV (anti-HIV 1 and 2) and HTLV (anti-HTLV 1 and 2). The serological tests on the donors were repeated six months after the harvesting procedure. The tissues were not released for use until after the final results from the above tests had been obtained. Tissue donated by patients whose serological tests for infectious diseases in any of the samples were positive, or who fell within the exclusion criteria of the protocol, was discarded (Table 1) .
Harvesting of bone tissue from the femoral head was done in a surgical environment, by a medical team specializing in primary hip arthroplasty procedures. The tissue removed was subjected to two sample collections for culturing and microbiological tests, over the entire length of the bone tissue. One sample was for culturing fungi and the other was for culturing bacteria. After collection of material for microbiological tests, the tissue was washed in physiological solution using 1 g of cefazolin (500 mL of 0.9% physiological serum for 1 g of cefazolin). All the soft tissues, muscle insertions and periosteum were then cleaned so that the material could be packed in tripled-sealed sterile packaging and were sent to the tissue bank. The tissues selected were stored in sterile receptacles Este é um artigo Open Access sob a licença de CC BY-NC-ND that were placed in a freezer set at −80 • C, with storage validity for up to five years after harvesting, in accordance with the ideal temperature conditions and the standards established by the National Sanitary Surveillance Agency (ANVISA) and the American Association of Tissue Banks (AATB). All the results from serological tests were documented and filed in the donors' records, and were cautiously verified by the biologists and nurses responsible for the bone bank. The cadavers were carefully selected and evaluated in accordance with the standards and guidelines established by AATB and ANVISA. The potential musculoskeletal tissue donors were brain-dead patients aged 18-70 years whose families consented to organ donation. The material was removed in a surgical environment by a specialized team consisting of four orthopedists, a biologist, a nurse and a nursing technician. After collection, the material was subjected to the same selection, examination and storage criteria as the material collected from donors.
The data were analyzed using the SPSS 13.0 software. The categorical variables were described as percentages and the continuous variables, as means and standard deviations. The chi-square test was used for categorical variables and Student's t test was used for continuous variables. (42%) and 44 men (58%). There was no significant difference in the number of rejections in relation to sex (p = 0.135) or age (p = 0.523), among the grafts coming from donors ( Fig. 1) .
Results

Out
The main cause of rejection was a positive serological test for the hepatitis B virus, which accounted for 48 rejections (63.15%). Positive serological tests for cytomegalovirus accounted for four rejections (5.2%), followed by positive serological tests for the hepatitis C virus, with two rejections (2.6%); toxoplasmosis, with two (2.6%); HTLV, with one (1.3%); and syphilis, with one (1.3%). Bacterial contamination accounted for two rejections (2.6%); Streptococcus sp. was found in both of these cultures. Contamination by filamentous fungi accounted for three rejections (3.9%). The other rejections were for other reasons, in accordance with the exclusion criteria. None of the material in the present study was found to be serologically positive for HIV or anti-T. cruzi (Table 2) .
Among the 43 cadavers, 27 (62.8%) were men and 16 (37.2%) were women. The mean age was 37.84 ± 10.32 years. Tissues from six cadavers were discarded (13.9%). There was no significant difference in the number of rejections in relation to sex (p = 0.21) or age (p = 0.252) (Fig. 2) .
The main cause of rejection among the cadavers was a positive serological test for the hepatitis C virus, which accounted for three rejections (50%). A positive serological test for toxoplasmosis was responsible for one rejection (16.6%). The others were excluded for other reasons, in accordance with the exclusion criteria (Table 3) . 
Discussion
Bone grafts in orthopedic surgery are becoming more and more frequently used, in tumor resection procedures, spinal surgery, revision on hip and knee prostheses and procedures dealing with sequelae of trauma. [9] [10] [11] [12] [13] Use of homologous bone grafts from tissue banks has been shown to be advantageous in many respects: there is no need for a secondary surgical access to remove tissue and it is possible to obtain a large quantity of material and a variety of anatomical forms. 14, 15 Other advantages include their biocompatibility, low immunogenicity and modest operational cost. Every year, around 150,000 musculoskeletal allografts (including bone, tendon and cartilage) are used by orthopedic surgeons in the United States. 2 Differing from other transplants, the bone rejection rate is minimal and patients do not require immunosuppressant medications. Contamination of the bone graft material is not a rare event, and the incidence of rejection reported in the medical literature ranges from 17% to 50%. [9] [10] [11] [12] [13] This variation in the bone tissue rejection rate is related to the incidence of infectious-contagious diseases in the region and also to the care and protocols established for harvesting and handling tissues. [12] [13] [14] [15] Because of the rigorous protocol followed in our tissue bank, our rejection rate after harvesting the bone tissue has so far been 40.5%. According to records in the current literature, the incidence of contamination in bone graft material coming from cadavers is higher than the rate among donors. [10] [11] [12] [13] The rejection rate for musculoskeletal tissues harvested from cadavers is related to the length of time between death and tissue removal. 13 Although the risk of virus transmission by means of musculoskeletal allografts is considered to be low, the greatest disadvantage in using bone allografts is the possibility of transmitting diseases. Tomford 7 reported four cases of HIV transmission and three of hepatitis C transmission after bone graft donation in the United States, up to 1995. After the confirmations of these cases, the AATB formulated rigorous protocols to be followed by tissue banks and care to be taken in choosing donors and harvesting, storing and processing tissues. Since then, according to the AATB, and in conformity with the guidance and standards established, the chance of HIV transmission in bone transplants in the United States has been one in 25 million. 4 In Brazil, no similar statistical data are yet available. In our tissue bank, there have not been any records of disease transmission to bone graft recipients so far.
Recent studies have noted that frozen bone grafts that had been properly stored, and for which the criteria for protection against contaminations had been followed, did not present alterations to their structure and maintained their qualities for an indeterminate length of storage. 3 Nonetheless, in our service, we have determined that a period of five years, counted from the date of harvesting, is the limit for using stored grafts, in accordance with the standards recommended by ANVISA and AATB.
Frozen bone grafts obtained under aseptic conditions function as the basis for bone neoformation and act more in an osteoconductive than an osteoinductive manner. In our tissue bank, we do not use sterilization by means of radiation. The tissues are frozen while fresh and are processed in a clean and sterile area (air class 100 by means of laminar flow in the processing area). For this reason, the protocols and care in harvesting the material are followed rigorously. If there is any type of contamination, the tissues are discarded. In this manner, the recipient's safety is assured and the risks of disease transmission are reduced to insignificant levels.
At 
Conclusion
Grafting of bone material coming from tissue banks has been shown to be safe and is increasingly used in high-complexity orthopedic procedures. There is a risk of transmission of infectious-contagious diseases, but this potential risk of contamination of the recipient can be reduced if appropriately rigorous microbiological monitoring is undertaken.
In the present study, there was a higher rejection rate for tissue from donors (47.8%) than for tissue from cadavers (13.9%). This was probably due to the greater age of the donors than that of the cadavers and, consequently, the greater length of exposure to infectious-contagious diseases.
